CIENCIASMEDICASNEWS: Medical News | Medical Articles: Ensuring safer and effective pharmaceutical formulations by XRD

viernes, 2 de agosto de 2019

Medical News | Medical Articles: Ensuring safer and effective pharmaceutical formulations by XRD

	August 2, 2019
	Pharmacy / Pharmacology
	The latest pharmacy / pharmacology news from News Medical

Ensuring safer and effective pharmaceutical formulations by XRD

From drug discovery and preformulating studies to scaling up in the manufacturing process in the plant and finally through QA/QC validation, X-ray diffraction (XRD) is a gold standard method in the determination of polymorphic and salt screening, percentage of crystallinity and stability/reactivity studies of the final API.

Pipette+ Smarter, Connected Pipetting

Don't miss this opportunity to learn more about Pipette+. Its award-winning design provides smart connected pipetting using Andrew Alliance Bluetooth electronic pipettes, co-developed with, and manufactured by Sartorius.

Find Out More

Advancing the Development of Cannabinoid-derived Pharmaceuticals

The International Cannabinoid-Derived Pharmaceuticals Summit is returning this September to provide the primary industry platform for the advancement of cannabinoid-derived pharmaceuticals. This event is the first of its kind and will take place September 10-12, 2019, in Boston, MA.

Learn More

	Using LIMS to Comply with Pharmaceutical Regulations In order to discuss compliance with Part 11, Annex 11, and recent regulatory guidances data integrity and temporary memory, some basic information about LabVantage software functionality and some assumptions about the deployment and use of LabVantage software in a customer setting.

	Resveratrol shows promise for anxiety and depression A new study has shown that the compound resveratrol found in red wine demonstrates stress relieving effects in anxiety and depression. This could be due to resveratrol’s ability to control an enzyme in the brain that is liked to stress say the researchers from the University at Buffalo in collaboration with Xuzhou Medical University in China.

	New drug provides hope for patients with Duchenne muscular dystrophy Duchenne muscular dystrophy (DMD) is a genetic, neuromuscular disease in which a patient lacks dystrophin, a structural protein present within muscle cells. This leads to inflammation and necrosis of muscles and gradual replacement of muscle tissue with fat and fibrous tissues resulting in muscle weakness.

	New leukemia treatment developed from common wild flower Researchers at Birmingham University have discovered how to turn a compound from a common wildflower called Feverfew into a new treatment for cancer. The team found a way to extract the naturally-occurring substance, called parthenolide, from the plant’s leaves and modify it so that it could destroy chronic lymphocytic leukemia (CLL) cells.

	Computer-generated flu vaccine enters clinical trials in the US A seasonal flu vaccine has been developed at Flinders University in South Australia and is set to be tested in clinical trials in the US. The vaccine has been created with artificial intelligence and scientists claim that it is more effective than the traditional seasonal flu vaccine.

	Researchers publish review on serial femtosecond crystallography Researchers from the Moscow Institute of Physics and Technology have published a review on serial femtosecond crystallography, one of the most promising methods for analyzing the tertiary structure of proteins. This technique has rapidly evolved over the past decade, opening new prospects for the rational design of drugs targeting proteins previously inaccessible to structural analysis. The article came out in the journal Expert Opinion on Drug Discovery.